Table 2.
Genetic and MRI data for participating individuals
| Variables | All ICH Survivors | ICH Survivors with no Dementia at 6 months | ||
|---|---|---|---|---|
|
| ||||
| No. 397 | % 100 | No. 257 | % 100 | |
|
| ||||
| MRI Imaging Data | ||||
| Cerebral MBs (Presence) | ||||
| - Any location | 270 | 68 | 180 | 70 |
| - Strictly Lobar | 123 | 31 | 86 | 33 |
| - Strictly Deep | 111 | 28 | 70 | 27 |
| - Mixed | 36 | 9 | 24 | 9 |
| CMBs Count (Any Location) | ||||
| - 0 | 127 | 32 | 77 | 30 |
| - 1 or 2 | 92 | 23 | 62 | 24 |
| - 2 to 4 | 79 | 20 | 51 | 20 |
| - ≥ 5 | 99 | 25 | 67 | 26 |
| MRI-WMH Volume | 17.4 | 15.8 | ||
| (Median, IQR in cc) | (7.2 - 35.1) | - | (7.3 - 28.9) | - |
|
| ||||
| APOE Genotype | ||||
| APOE ε2 (Minor Allele Frequency) | 0.11 | - | 0.08 | - |
| APOE ε4 (Minor Allele Frequency) | 0.17 | - | 0.20 | - |
Abbreviations: APOE = Apolipoprotein E Gene, CMBs = Cerebral Microbleeds, ICH = Intra-Cerebral Hemorrhage, IQR = Inter-Quartile Range, MRI-WMH = MRI-defined White Matter Hyperintensity.